baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out BIIB/ DE000VD4PT76 /

14/06/2024 20:03:22	Chg.-0.190	Bid21:59:53	Ask21:59:53	Underlying	Strike price	Expiration date	Option type
3.630EUR	-4.97%	- Bid Size: -	- Ask Size: -	Biogen Inc	194.55 USD	31/12/2078	Call

GlobeNewswire 12:04 BIOGEN STOCK NOTICE: Lose Money on your Biogen Inc. (Nasdaq: BIIB) Investment? BFA Law Encourages Yo...

GlobeNewswire 14/06 DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...

GlobeNewswire 14/06 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...

GlobeNewswire 14/06 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...

GlobeNewswire 13/06 Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors of Class Action Filing and Encourages Inve...

GlobeNewswire 13/06 Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

GlobeNewswire 13/06 DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...

GlobeNewswire 13/06 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...

GlobeNewswire 13/06 BIOGEN LEGAL DEADLINE: If You Lost Money on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Enco...

GlobeNewswire 13/06 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...

GlobeNewswire 12/06 BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...

GlobeNewswire 11/06 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors

GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 11/06 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...

GlobeNewswire 11/06 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...

GlobeNewswire 11/06 BIOGEN NOTICE: If You Suffered Losses on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Reminde...

TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug

GlobeNewswire 10/06 BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...

GlobeNewswire 10/06 Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to C...

GlobeNewswire 10/06 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...

GlobeNewswire 10/06 FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...

GlobeNewswire 08/06 BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal ...

GlobeNewswire 07/06 BIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc...

GlobeNewswire 07/06 Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) S...

GlobeNewswire 07/06 DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...

BVT Knock-Out BIIB/ DE000VD4PT76 /

If you wish to receive reply to your feedback, please provide your email address.